This presents the resource-based theory of competitive advantage as a framework for describing, understanding, and predicting the adoption and dissemination pharmacy service innovations into routine practice. The theory argues that sustainability of any business innovation (e.g., pharmacy service) is based upon (1) the internal resources of the firm offering it, (2) the firm’s capabilities in using those resources, (3) the competitive advantage to the firm of its resources and capabilities, (4) the attractiveness of the market in which it competes, and (5) the innovation’s contribution to financial performance of the firm.
Hospital Formulary - presentation gives the detail idea about Hospital formulary, its advantage, disadvantage, how to prepare Hospital formulary and much more. this will be useful for Pharm.D-IV YEAR students, which was in their Hospital pharmacy subject. regards APOLLOJAMES
Purchasing and Inventory control in drug store
by Mrs. Anjua Parkhe and Mrs. Priyanka Kalamkar
Assistant Professor
Sraaswathi Vidya Bhavans College Of Pharmacy, Dombivli
Drug Information Services, Drug information Sources, Illegal DIC, Drug Information Bulletin, Classification of scientific literature, services offered bu drug information services
Pharmacy and Therapeutic Committee (PTC) & Hospital Formulary
The Pharmacy and Therapeutic Committee (PTC) is an advisory group that considers essentially all the matters related to the use of drugs in a hospital including evaluation of drugs & dosage forms and safe use of investigational drugs.
What is a pharmacy and therapeutics committee?
Pharmacy and Therapeutics (P&T) is a committee at a hospital or a health insurance plan that decides which drugs will appear on that entity's drug formulary.
The formulary system is a method by which physicians and pharmacists, working through a Pharmacy and Therapeutics Committee of the medical staff, evaluate and select medications for use in a hospital.
the hospital formulary system provides the information for procuring,prescribing,dispencing and administrative of drug under non proprietary names and instance where drugs have both names.
Teaching the history of pharmacy to young people is a challenge but it can be done if delivered in an interesting and engaging way. These slides summarize what I share with my students.
Includes information about Education and training programs planned in hospital by hospital pharmacy. Useful for B Pharmacy 4th year student, and for M pharmacy (clinical pharmacy) student.
Healthcare is Getting Disrupted... Is Pharmacy Ready?Hillary Blackburn
Change is coming for the healthcare industry, particularly as digital disruption is happening. Within the broader healthcare industry, pharmacy will be impacted and should be ready to help the profession grow and thrive.
Hospital Formulary - presentation gives the detail idea about Hospital formulary, its advantage, disadvantage, how to prepare Hospital formulary and much more. this will be useful for Pharm.D-IV YEAR students, which was in their Hospital pharmacy subject. regards APOLLOJAMES
Purchasing and Inventory control in drug store
by Mrs. Anjua Parkhe and Mrs. Priyanka Kalamkar
Assistant Professor
Sraaswathi Vidya Bhavans College Of Pharmacy, Dombivli
Drug Information Services, Drug information Sources, Illegal DIC, Drug Information Bulletin, Classification of scientific literature, services offered bu drug information services
Pharmacy and Therapeutic Committee (PTC) & Hospital Formulary
The Pharmacy and Therapeutic Committee (PTC) is an advisory group that considers essentially all the matters related to the use of drugs in a hospital including evaluation of drugs & dosage forms and safe use of investigational drugs.
What is a pharmacy and therapeutics committee?
Pharmacy and Therapeutics (P&T) is a committee at a hospital or a health insurance plan that decides which drugs will appear on that entity's drug formulary.
The formulary system is a method by which physicians and pharmacists, working through a Pharmacy and Therapeutics Committee of the medical staff, evaluate and select medications for use in a hospital.
the hospital formulary system provides the information for procuring,prescribing,dispencing and administrative of drug under non proprietary names and instance where drugs have both names.
Teaching the history of pharmacy to young people is a challenge but it can be done if delivered in an interesting and engaging way. These slides summarize what I share with my students.
Includes information about Education and training programs planned in hospital by hospital pharmacy. Useful for B Pharmacy 4th year student, and for M pharmacy (clinical pharmacy) student.
Healthcare is Getting Disrupted... Is Pharmacy Ready?Hillary Blackburn
Change is coming for the healthcare industry, particularly as digital disruption is happening. Within the broader healthcare industry, pharmacy will be impacted and should be ready to help the profession grow and thrive.
Overview of aspects of pharma's value added services and its primary aspects to deliver them.
Learn what others do and reflect how it's an opportunity for your pharma company..
Market Access 101: Connecting Access Challenges to Brand OpportunitiesOgilvy Health
Last week, our payer marketing team hosted their inaugural All Access Festival event in our NJ headquarters. This rock concert-inspired event gave our colleagues an inside look at fundamental elements of optimizing market access strategies. Take a look at the presentation chock-full of insights from this event.
Strategic ThinkingExamine how strategic thinking and planning affe.pdfakkucomm
Strategic Thinking
Examine how strategic thinking and planning affect the internal and external environments
specific to Nursing Homes services by completing the following:
Identify and analyze the various elements that comprise your health care industry\'s trends and
policies.
Define and explain the economic and business conditions, premises, policies, and other related
forces that form the basis for generating change in Nursing Homes.
Identify and analyze specific issues revolving around health care management and policy
analysis specific to this organization.
Examine the different types of markets in the health care system and the determinants of supply
and demand in each market specific to the selected organization.
Your two-page report should contain an introduction and a conclusion. Resources and citations
should be formatted according to APA (6th edition) style and formatting.
Solution
1). health care industry\'s trends will exert significant impact on capital investments,allocation of
resources, innovation, and share of industry profits.these extraordinary achievements, the cost,
quality, and accessibility of health care have become major legislative and policy issues.
Substantial increases in the cost of health care have placed considerable stress on federal, state,
and household budgets, as well as the employment-based health insurance system. Health care
quality varies widely, even after controlling for cost, source of payment, and patient preferences.
Many Americans lack health insurance coverage at some point during any given year. The costs
of providing uncompensated care are a substantial burden for many health care providers, other
consumers, and tax payers.
2.the economic and business conditions, premises, policies, and other related forces that form the
basis for generating change in Nursing Homes business or reward suppliers that reduce costs or
enhance quality with substantially increased volume or higher payments. CMS has limited ability
to contract selectively with providers or use competitive bidding. Even straightforward
purchasing initiatives, such as competitive bidding for durable medical equipment (DME), have
generated considerable resistance, despite the success of a pilot project for DME competitive
bidding
3.issues revolving around health care management and policy analysis specific to this
organization
a). Health Care Expenditures Are Once Again Rising Dramatically
B. Health Care Quality Varies
c).Economy Typically Relies on Market Competition
4.different types of markets in the health care system and the determinants of supply and demand
in each market specific to the selected organization.
Competitive pressures for cost containment have spurred the development of new forms of
health care financing and delivery. Government payors have adopted new forms of payments for
health care providers to slow health care inflation. Private payors have adopted systems, such as
managed care and preferred provider organizati.
Running Head: PHYSICIAN
PHYSICIAN 7
Health Care Provider: Physician
Marcia Harrison
Strayer University
Professor Hwangi Lu
July 28, 2019
Physician
Introduction
A healthcare system should be well organized and should consist of trained personnel who mainly work with a company or an organization. Physicians, nurses, doctors, pharmacists are some of the examples of health care providers. This is a system that provides professional services to patients that are in high need of treatment as inpatients who are treated generally as outpatients. I decided to select physicians as health care providers and also as medical practitioners since they are always in demand in the medical field, day after another. This is a professional medical practitioner or by simple terms, a doctor who has completed highly advanced training in providing a range of mostly non-surgical health care to patients. A physician should have adverse knowledge in a medical specialty. The main concern is to maintain, restore, and promote health via the study, treatment, and diagnosis of a disease of patients to ensure their wellbeing.
Direct Impact of a Physician
Most companies direct the efforts of their marketing towards physicians to the consumers who are their patients; the shots are put in the physicians through the sale of drugs and also by advertising in most of the medical journals. Most of the largest chunk is put in place towards the detailing of marketing expenditure through advertisement. Some direct adverse impacts towards physicians are the misleading claims, indications that are unapproved and also overstated clinical issues. It has led to patients heading to physicians on a matter regarding well preventive healthcare (Machanda, 2005) since most drug adverts have left patients having an excellent aid of discussions with their physicians regarding treatment through which only safe drugs are allowed.
Physicians and their patients have put into caution through dealing with advertisement of drugs as they use forums which are web-based for their advertisements as they have a literature of promotion on their background which makes them be excluded in the blacklist by companies and by the agency of the regulatory. The detailing through rifeness over the drugs life has been adopted as an explanation of better effectiveness and efficiency of physician firms and improvement of patient’s health. As an industry, it plays a vital role in the economy of the world and also promoting the welfare of the consumers who are the citizens of the nation towards the healthcare industry.
Strategy for a Physician
Data integrity is a critical strategy that physicians ought to adopt for the statistical review and pattern utilization as a technological step in the medical field, this will help in recoding the patients ...
Global pharmaceutical companies are modeled with a supply chain, which ensures that the right drug reaches the right people at the right time and in the right condition. The supply chain also ensures 100% product availability at optimum cost by carrying huge inventory, which maintains 100% fill rate. Manufacturers are trying to cut down development time to save costs. For example, a drug manufacturer who can trim development time by 19% can save up to USD 100 million. But if a drug is getting delayed to reach the market, the time delay costs the company around USD 1 million a day. So, pharmaceutical companies today are designing the supply chain to be as responsive as possible to reduce entry time to the market thereby increasing profit margins.
Here's what bio-pharma organizations need to know when transforming the promotional material review and approval process from a transactional requirement to a competitive advantage.
This presentation describes how pharmacists and pharmacies can innovate when delivering professional services. Goes beyond one-stop-shopping and low price services.
Running head MARKETING 1MARKETING 5MARKETINGI.docxjeanettehully
Running head: MARKETING 1
MARKETING 5
MARKETING
Institution Affiliation
Student Name
Date
SNHU Pet Supply Company is introducing a new food product for cats and dogs. The company has a good reputation due to the health food products that they produce. The new food product is a good substitute for other animal food products that are in the market, (Adams, 2015). The main objective of this paper is to determine whether the product will meet the needs or wants of the target consumers and establish a marketing strategy.
To effectively market the new product, it is essential to do SWOT analysis. It is importan to identify the strength, weaknesses, opportunities and threats of the food products.
Animal food products have many strengths that include ingredients are from quality meet, it is a healthy alternative, and it has a unique brand name. Some of the weaknesses include the products are expensive; the company lacks social media platforms. Therefore, the products cannot be fully marketed, and the quality of the ingredients is high, which means that the production cost is high too. Some of the opportunities that exist include the trending of a healthy lifestyle, competitors are slow in coming up with healthy pet food, and new brands may be appropriate especially for customers who are looking for a change, (Armstrong & Kotler, 2015). Some of the threats that the company will face include cheaper alternatives from the competitors and competition with companies that are present on social media. The company should utilize its opportunities to gain more customers. Moreover, the company should look for ways to improve on its weaknesses by having a social media platform where they can market their products.
The organization will concentration its marketing efforts on customers that live in the Colorado area. The median income of people who live in this area is $72,000. The median age of people that live in this area is 39 years old. Majority of people living in this area are married and well educated with a flexible career, (Graham, 2018). The target population are not committed to a healthy lifestyle. However, they spend money on high-quality products and luxurious products. The number of people that live in this area is 80206.
For human being and pets to survive, they have to eat. The new pet food products fulfil the needs and want of the target market by offering health, and sustainable food that replicates their lifestyle habit. The target population is willing to spend some extra cash on high-quality products. The product satisfies more than just the need of the target market by ensuring that the desires of having an active and energetic pet are met.
First and foremost, I would recommend that the company utilizes an online marketing strategy. The company should come up with a website where customers can access the price and product information. The second strategy that I would recommend is to promote the products that are in store ...
Similar to Pharmacy practice research and competitive advantage theory (20)
If you want to be a better leader, you should read more -- either fiction or non-fiction. This slide presents the lessons from one book that I read many years ago. The lessons have stuck with me.
Much of our ideas about motivating others are inconsistent with what science says. This presentation describes three commonly used methods to motivate. Only one is under the control of all pharmacists and pharmacy personnel.
Whenever people work together on things of importance, there will be disagreements and conflict. Understanding conflicts and how to work them out is a key responsibility of professionals and leaders. When handled well, conflicts can improve relationships, solve difficult problems, and influence change in organizations.
The following slides describe how to have trusting professional relationships. Mutual trust between partners is fundamental to commitment and engagement.
The following slides describe how pharmacists can have better professional relationships which are fundamental to pharmacy practice. Effective professional relationships are vital in leading others, teaching and coaching performance, negotiating win-win solutions, and resolving conflict in pharmacy organizations. Good professional relationships help improve communications, make work more enjoyable, and increase opportunities for success.
These slides cover the concepts of situational leadership -- a group of theories that highlight the role of context in effective leadership. The ability to read a situation and apply the right leadership style is critical for successful leadership.
Ethical leadership can be defined as the process through leaders attempt to accomplish morally defensible goals in a morally defensible manner. These slides review what it means to be an ethical leader and the process for being one.
Pharmacists can learn from the accumulated wisdom of the leadership literature to be better leaders. These slides summarize the major ideas covered in Chapter 2 of "Leadership for Pharmacists". It provides a brief review of leadership theories and what pharmacists can learn from them.
This is an updated slide deck discussing what students should consider when starting a career in community pharmacy practice. There really are a lot of opportunities if pharmacists are willing to do what it takes to succeed.
This chapter discusses the topic of motivation and the science behind it. It differentiates motivation from the concepts of morale and performance. It examines key motivation theories and what they say about what drives human behavior. The chapter identifies important lessons for pharmacists from each theory. Throughout, it describes misconceptions relating to things that motivate us and others and how misconceptions can lead to unintended behavioral consequences.
These slides accompany Chapter 7 from Leadership for Pharmacists. It lays out different types of problems faced by pharmacists and issues to consider. It identifies some cognitive biases and bad decision-making processes that can prevent good solutions. A systems approach using a step-by-step process for making good decisions is presented.
This is a basic introduction to leadership from Chapter One from Leadership for Pharmacists. It explains why pharmacists should learn about leadership by using statements from professional organizations and the pharmacy literature. Leadership and management are defined and contrasted. The role of power in leading change is discussed along with a discussion that contrasts how leaders and managers use power differently. The chapter ends by providing a short summary of what is known about leadership.
This is a pitch deck template for pharmacy business models. It is for pharmacy projects that are in the advanced stages of planning. A previous 9 slide pitch deck without financials is available for early stage strategic planning.
The business and people behind a new service or program are critical for stakeholders to evaluate a business plan. This presents what is needed in the plan's business description and why.
Pharmacies serve consumer, business, and government markets. Each market requires different marketing strategies. This presentation describes what pharmacists need to know about B2C, B2B, and B2G marketing.
More from Virginia Commonwealth University School of Pharmacy (20)
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...Kumar Satyam
According to the TechSci Research report titled “India Diagnostic Labs Market Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2019-2029,” the India Diagnostic Labs Market was valued at USD 16,471.21 million in 2023 and is projected to grow at an impressive compound annual growth rate (CAGR) of 11.55% through 2029. This significant growth can be attributed to various factors, including collaborations and partnerships among leading companies, the expansion of diagnostic chains, and increasing accessibility to diagnostic services across the country. This comprehensive report delves into the market dynamics, recent trends, drivers, competitive landscape, and benefits of the research report, providing a detailed analysis of the India Diagnostic Labs Market.
Collaborations and Partnerships
Collaborations and partnerships among leading companies play a pivotal role in driving the growth of the India Diagnostic Labs Market. These strategic alliances allow companies to merge their expertise, strengthen their market positions, and offer innovative solutions. By combining resources, companies can enhance their research and development capabilities, expand their product portfolios, and improve their distribution networks. These collaborations also facilitate the sharing of technological advancements and best practices, contributing to the overall growth of the market.
Expansion of Diagnostic Chains
The expansion of diagnostic chains is a driving force behind the growing demand for diagnostic lab services. Diagnostic chains often establish multiple laboratories and diagnostic centers in various cities and regions, including urban and rural areas. This expanded network makes diagnostic services more accessible to a larger portion of the population, addressing healthcare disparities and reaching underserved populations. The presence of diagnostic chain facilities in multiple locations within a city or region provides convenience for patients, reducing travel time and effort. A broader network of labs often leads to reduced waiting times for appointments and sample collection, ensuring that patients receive timely and efficient diagnostic services.
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a significant driver for the demand for diagnostic lab services. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require regular monitoring and diagnostic testing for effective management. The rise in chronic diseases necessitates the use of advanced diagnostic tools and technologies, driving the growth of the diagnostic labs market. Additionally, early diagnosis and timely intervention are crucial for managing chronic diseases, further boosting the demand for diagnostic lab services.
For those battling kidney disease and exploring treatment options, understanding when to consider a kidney transplant is crucial. This guide aims to provide valuable insights into the circumstances under which a kidney transplant at the renowned Hiranandani Hospital may be the most appropriate course of action. By addressing the key indicators and factors involved, we hope to empower patients and their families to make informed decisions about their kidney care journey.
3. School of Pharmacy
Learning Objectives
LO 1: Discuss pharmacy practice innovations
LO 2: Describe resource-based theory of competitive advantage
LO 3: Explain its role in advancing research in pharmacy practice
innovations
4. Fact:
~ 3 out of 4 pharmacists (>300 thousand
total) work in community pharmacies in
the United States
https://www.bls.gov/oes/current/oes291051.htm
7. Some reasons pharmacists are underutilized
1. Structure & financing of healthcare system
2. Product-focused business model has been
profitable until recently
3. Pharmacist complacence & passivity
4. Unclear value proposition for pharmacist services
8. FACT
“Pharmacy services cannot be sustained over time if
they do not cover the costs of providing them.”
Holdford DA. Chapter 14: Providing Sustainable Pharmacy Services in Ambulatory Care. Introduction to Acute and Ambulatory Care
Pharmacy Practice. 2nd ed. Bethesda, Maryland: American Society of Health-Systems Pharmacists. 2017.
10. Problem
Too many pharmacy practice innovations fail in the long run
Available models of practice research have yet to show the answer to
professional practice success
This presentation presents a framework from the business literature for
conducting research about innovations in pharmacy practice
11. Resource-based Theory Of Competitive Advantage
Interdisciplinary theory developed from marketing, management, ethics, law,
supply chain management, and general business
Provides a foundation for uniting innovation research streams into a single
coherent framework
In fact, it can serve as a general theory for research in pharmacy practice
13. Pharmacy practice
The provision of services by pharmacists and
pharmacy organizations to respond to the
medication-related needs of the people
14. Practice Innovations
Any changes in the provision of pharmacy perceived
as new by consumers, payers, or stakeholders
Types:
1. Service innovations
2. Service process innovations
3. Innovations in the service business model
15. Category Examples
Newservicesorservicebundles
Offering something new (e.g., specialty pharmacy services)
Finding new customers (e.g., veterinary pharmacy services)
Expanding a product line (e.g., adding ABMS to basic dispensing)
Growing services (e.g., moving into new international markets)
Changing the service bundle (e.g., unbundling MTM into
components)
Modifying existing service bundles (e.g., adding a private
counseling area)
Repositioning existing service bundle (e.g., promoting the
pharmacist in ads instead of merchandise)
16. Category Examples
Serviceprocessinnovations
Improvements in the patient journey from the hospital to home through
transitions in care programs
Pharmacy loyalty programs which reward patients for purchases
Use of practice guidelines and practice models
Retail clinics in pharmacies which permit one-stop health care for minor
ailments
Smart phone apps which combine medication reminders, gamified health
promotion, and other services on one device
Use of artificial intelligence to personalize care to patients
Electronic point-of-care technology that offers discounts or some other
form of value
Cashier-free stores which track items placed in carts by shoppers and
automatically charge customers when they leave the store with those
items
Shopping in pharmacies using augmented and virtual reality technology
17. Service Business Model Innovations
describe a major change in the way in which
services generate revenues and/or earn profits
18. Traditional Business Model for Community Pharmacy
Sale of
merchandise
– Out-of-pocket
(OOP)
– Third party
19. New Community Pharmacy Business Models
Fee-for-service: FFS generates revenue by selling services for a negotiated fee
• Immunizations
• MTM/CMR
• Health screening services (e.g., BP, cholesterol)
• Point of care testing (e.g., HIV)
Value Based: Healthcare delivery model in which providers, pharmacies and
pharmacists, are paid based on patient health outcomes
Social Business Models: Non-profit organization where revenues come from
donations, investment returns, and other non-traditional sources
20. Category Examples
Businessmodelinnovation
Hospital Inpatient Value-Based Purchasing Program: Medicare
compensation to hospitals based on value-based purchasing measures
relating to clinical processes, efficiency, & patient outcomes/experience.
Federal 340B Drug Pricing Program: allows eligible healthcare institutions
to purchase outpatient drugs at significantly reduced prices from drug
manufacturers. Savings can be used to expand service to Medicaid
patients, the uninsured, and some other patients.
"Incident to" models in which pharmacists charge Medicare for clinical
services provided under a physician's National Provider Identifier (NPI).
Medicare Star Rating Program: uses a star rating system to assess the
performance of Medicare Advantage and prescription drug (Part D) plans.
Compensation to plans is based on scores (1 to 5 stars).
Pay-for-performance contracts: reward or punish providers depending on
performance on measures of quality and efficiency.
23. RESOURCE-BASED THEORY (RBT) OF
COMPETITIVE ADVANTAGE
Long-term success of a pharmacy service innovation is based on
1. What the firm has (Firm Resources)
2. What the firm does (Firm Capabilities)
3. Competition (Sustained Competitive Advantage)
4. The market in which it competes (Market Attractiveness)
5. How well the firm performs financially (Financial Performance)
24. RBT considers innovating to be an evolutionary process
founded on the following premises:
1. Demand continually varies in market segments
2. Consumers and firms lack perfect information
3. Humans are motivated by self-interest
4. Firms seek profits
5. The firm's heterogeneous resources are physical, human, and organizational
capital
6. Competition is the source of innovation and it comes from a firm’s ability to
recognize, understand, create, select, implement, and modify strategies to its
situation
7. Financial performance between firms varies depending on their resources and
capabilities
25. RBT argues that…
Pharmacy firms achieve sustainable competitive advantage by innovating
in ways that are hard to substitute for or imitate
Success is also the result of the people involved, the organization(s) behind
the innovation, context surrounding its implementation and dissemination,
and the innovation’s benefits to stakeholders and the firm
26. Financial
Performance
Market
attractiveness
Barriers to entry of competitors
Rivalry among industry incumbents
Threat of substitutes to what a firm
offers
Bargaining power of customers of the
firm's outputs
Bargaining power of suppliers of the
firm's inputs
Sustained
competitive
advantage
Firm Resources: Financial, Physical,
Legal, Human, Organizational,
Informational, Relational
Firm Capabilities: Managerial,
Marketing, Financial, Technical
Key constructs and
their relationships
in resource-based
theory
27. Financial
Performance
Market
attractiveness
Barriers to entry of competitors
Rivalry among industry incumbents
Threat of substitutes to what a firm
offers
Bargaining power of customers of the
firm's outputs
Bargaining power of suppliers of the
firm's inputs
Sustained
competitive
advantage
Firm Resources: Financial, Physical,
Legal, Human, Organizational,
Informational, Relational
Firm Capabilities: Managerial,
Marketing, Financial, Technical
Key constructs and
their relationships
in resource-based
theory
STRENGTHS,
WEAKNESSES
OPPORTUNITIES,
THREATS
28. Using RBT to Understand
Appointment-Based Medication
Synchronization (ABMS)
29. Appointment-Based
Medication
Synchronization (ABMS)
Patient enrolls, MD
Contacted
Patient and pharmacist
discuss medication
regimens, establish
monthly pick-up date
One week prior to pick-
up: patient is called to
confirm refills, clarify
modifications, address
concerns
Pharmacist reviews
medications, obtains
necessary refill orders,
and addresses
insurance changes
Patient picks up
medication on
arranged day,
Pharmacist discusses
changes and questions
Holdford DA, Inocencio TJ. Adherence and persistence associated with an
appointment-based medication synchronization program. J Am Pharm Assoc
(2003). 2013 Nov-Dec;53(6):576-83. .
30. Appointment-Based
Medication
Synchronization (ABMS)
Patient enrolls, MD
Contacted
Patient and pharmacist
discuss medication
regimens, establish
monthly pick-up date
One week prior to pick-
up: patient is called to
confirm refills, clarify
modifications, address
concerns
Pharmacist reviews
medications, obtains
necessary refill orders,
and addresses
insurance changes
Patient picks up
medication on
arranged day,
Pharmacist discusses
changes and questions
Holdford DA, Inocencio TJ. Adherence and persistence associated with an
appointment-based medication synchronization program. J Am Pharm Assoc
(2003). 2013 Nov-Dec;53(6):576-83. .
How does
this offer
competitive
advantage?
31. What resources and capabilities
might offer competitive advantage
with this innovation?
32. Firm Resource Type Examples
Financial cash, access to credit
Physical adequate space/privacy for counseling, workflow, synchronization software
Legal Prescriptive authority, collaborative practice agreements, provider status,
credentialing
Human Pharmacist competence, education and training for personnel,
communication skills, motivation, leadership skills, professional satisfaction,
pharmacist knowledge of and attitude toward cognitive services,
pharmacists’ self-efficacy, autonomy, attitude of staff, sufficient staff
Organizational Culture of pharmacy, innovative practice orientation, script volume,
management support, reputation with the community
Informational Access to patient records, access to reference literature, evidence of benefits
of services
Relational Relationships with physicians, pharmacist/patient relationship, support from
professional organizations and/or government, external advisors or mentors
33. Firm Capability
Category
Examples
Managerial Use of pharmacy technicians, delegation of tasks, organizational
flexibility, human resources management
Marketing Customer service, market segmentation, proactive entrepreneurial
behaviors, services management, active relationship management
with stakeholders
Financial Cross-subsidization of expanded services, financial management
Technical Being patient-centered, use of protocols, interaction with other
pharmacists, use of a documentation system, learning from others,
working in interprofessional teams
34. Sustainable Competitive Advantage
Achieved by accumulating and using resources to serve customer interests
in ways that are hard to substitute for or imitate
In general, intangible resources (e.g., pharmacist’s expertise, proprietary
software) offer more sustainable competitive advantages because they are
difficult to copy
Tangibles (e.g., drive-thru, counseling areas) offer only short term
competitive advantages
36. Financial
Performance
Market
attractiveness
Barriers to entry of competitors
Rivalry among industry incumbents
Threat of substitutes to what a firm
offers
Bargaining power of customers of the
firm's outputs
Bargaining power of suppliers of the
firm's inputs
Sustained
competitive
advantage
Firm Resources: Financial, Physical,
Legal, Human, Organizational,
Informational, Relational
Firm Capabilities: Managerial,
Marketing, Financial, Technical
Sustained competitive
advantage is not
enough
37. Market attractiveness
Potential for success of an innovation in a
market (segment)
Ability of an innovating firm to exploit
market potential
An innovation may succeed in one market
segment but not another. The key is to
match competitive advantage to the right
segments
38. Porters Five
Forces Model
Rivalry
among
industry
incumbents
Barriers to
entry of
competitors
Threat of
substitutes to
what a firm
offers
Bargaining
power of
customers for
firm's outputs
Bargaining
power of
suppliers of the
firm's inputs
Porter, M.E. (March–April 1979) How Competitive Forces Shape Strategy, Harvard Business Review.
OPPORTUNITIES,
THREATS
39. Force Examples
Rivalry among industry
incumbents
Number of pharmacies, 24/7, omnichannel distribution
Barriers to entry of
competitors
Regulatory hurdles, economies of scale, limited networks
which make it difficult to enter or leave markets
Threat of substitutes to
what a firm offers
Substitutes for ABMS include status quo, medication
synchronization without appointment, automatic refills
Bargaining power of
customers for firm's
outputs
Major customers are PBMs (Express Scripts, CVS Caremark,
and OptumRx) and the Federal Government
Bargaining power of
suppliers of the firm's
inputs
Suppliers to pharmacy service providers are software
companies, labor, or other inputs.
40. Financial Performance
Typically refers to profits
Determined by (1) a firm’s competitive advantage over rivals and (2) the
attractiveness of the market in which it competes
“NO MONEY. NO MISSION.”
41. Financial Performance Depends on Perspectives of Decision
Makers
Decision Maker Interests
Patient
Out-of-pocket costs, personal convenience, impact on
medication adherence, satisfaction with providers
Physician
Affordability to patients, personal convenience, impact on
medication adherence, acceptability to health plans
Pharmacist Additional revenue, operating costs, costs of investment
Government Public health, public financing
Health Plan/ PBM/
Private Employer
Additional revenue, operating costs, costs of investment
42. School of Pharmacy
LO 3: EXPLAIN THE THEORY’S
ROLE IN ADVANCING
RESEARCH IN PHARMACY
PRACTICE
43. Comparing frameworks for evaluation pharmacy practice innovations
Resource Based
Theory
Donabedian Operations
Management
I.S. P-economics
Resources Structures Inputs Factors Medications
Competencies Processes Transformation
Processes
Factors Value added
services
Sustained
Competitive
Advantage
Intermediate
Outcomes
Outputs Strategies Intermediaries
Attractiveness of
Market
Patient clinical,
demographic, &
preferences
System Context of
implement-
ation
Perspective of
analysis
Financial
Performance
Outcomes Outputs Evaluations Economic, clinical,
humanistic
outcomes
I.S. = Implementation Science
45. Literature on innovation research
Fragmented and gives vague guidance about how to develop successful
pharmacy practice innovations
Different terminology and classifications for innovation concepts
RBT offers a way of harmonizing innovation research. As a theory, it:
• explains relationships
• offers hypotheses on the directional relationships of variables
• addresses innovations within the real-life context of competition
46. RQ1. How does the pharmacy practice literature explain the competitive advantages of professional
services?
RQ2. What pharmacy practice resources are associated with competitive advantage?
RQ3. What competencies of pharmacy practice are associated with competitive advantage?
RQ4: How would pharmacists’ competitive advantage change if they had access to new resources (e.g.,
full patient data)?
RQ5: How would pharmacists’ competitive advantage change with different competencies (e.g.,
entrepreneurial mindset)?
RQ6: Under what conditions of the pharmacy market does competitive advantage lead to financial
performance of firms?
RQ 7: What advances in market segmentation can be used to exploit the competitive advantages of
pharmacy practice innovations?
RQ8: What competencies of individual pharmacists are needed to maximize their contribution to the
competitive advantage of firms?
RQ9: What characteristics of markets (i.e., Porter’s five factors) positively influence innovations in
pharmacy practice?
RQ10: What constructs and dimensions define innovative pharmacy services and their contributions to
competitive advantage?
RQ11: What proportion of published pharmacy practice innovations are sustained 2 years past the initial
implementation and study phase?
RQ12: What resources and competencies are associated with financial performance of pharmacies?
47. Financial
Performance
Market
attractiveness
Barriers to entry of competitors
Rivalry among industry incumbents
Threat of substitutes to what a firm
offers
Bargaining power of customers of the
firm's outputs
Bargaining power of suppliers of the
firm's inputs
Sustained
competitive
advantage
Firm Resources: Financial, Physical,
Legal, Human, Organizational,
Informational, Relational
Firm Capabilities: Managerial,
Marketing, Financial, Technical
What pharmacy practice
resources and capabilities
are associated with
competitive advantage?
48. Financial
Performance
Market
attractiveness
Barriers to entry of competitors
Rivalry among industry incumbents
Threat of substitutes to what a firm
offers
Bargaining power of customers of the
firm's outputs
Bargaining power of suppliers of the
firm's inputs
Sustained
competitive
advantage
Firm Resources: Financial, Physical,
Legal, Human, Organizational,
Informational, Relational
Firm Capabilities: Managerial,
Marketing, Financial, Technical
What capabilities of
individual pharmacists are
associated with
competitive advantage?
49. Financial
Performance
Market
attractiveness
Barriers to entry of competitors
Rivalry among industry incumbents
Threat of substitutes to what a firm
offers
Bargaining power of customers of the
firm's outputs
Bargaining power of suppliers of the
firm's inputs
Sustained
competitive
advantage
Firm Resources: Financial, Physical,
Legal, Human, Organizational,
Informational, Relational
Firm Capabilities: Managerial,
Marketing, Financial, Technical
What advances in market
segmentation can be used
to exploit the competitive
advantages of pharmacy
practice innovations?
50. Financial
Performance
Market
attractiveness
Barriers to entry of competitors
Rivalry among industry incumbents
Threat of substitutes to what a firm
offers
Bargaining power of customers of the
firm's outputs
Bargaining power of suppliers of the
firm's inputs
Sustained
competitive
advantage
Firm Resources: Financial, Physical,
Legal, Human, Organizational,
Informational, Relational
Firm Capabilities: Managerial,
Marketing, Financial, Technical
What proportion of
published pharmacy
practice innovations are
sustained 2 years past the
initial implementation and
study phase?
51. Conclusion
Competition is a fundamental aspect of business and innovation
Innovations must achieve sustained competitive advantage and financial
performance
Resource-based theory of competitive advantage can serve as a general theory
for research in pharmacy practice and in the social and administrative sciences
Editor's Notes
OOP, Fee for product delivery
Always someone cheaper, more convenient. Not a competitive advantage. Commodity.
If you have it, you have advantage over those who don’t. If competitors have it, you do it better than them.
A popular framework for assessing the attractiveness of a market is Porter’s five forces.35 In this framework, the intensity of competition in a market is determined by five industry forces: barriers to entry of competitors, rivalry among industry incumbents, the threat of substitutes to what a firm offers, the bargaining power of buyers of the firm’s outputs, and the bargaining power of suppliers of the firm’s inputs. An attractive market is one where a competitive advantage can be profitably developed and maintained. An unattractive market is one where competition for customers is fierce and costly.
As you can see from this slide, the interests of different decision makers in medication use often diverge.
So let’s focus on the interests of health plans